(Q39785110)

14 September 2017

1 reference

title

Chemotherapy and genitourinary oncology. I. Bladder cancer (English)

1 reference

14 September 2017

Carter SK

1

1 reference

14 September 2017

language of work or name

1 reference

1 June 1978

1 reference

14 September 2017

published in

Cancer Treatment Reviews

1 reference

14 September 2017

volume

5

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

85-93

1 reference

The Use of Methotrexate in Advanced Carcinoma of the Bladder

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Cancer of the urogenital tract: bladder cancer. The accuracy of clinical vs. surgical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Cancer chemotherapy by continuous intra-arterial infusion of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

1 reference

7 January 2021

The chemotherapy of urologic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

A restudy of the first fourteen hundred tumors in the Bladder Tumor Registry, Armed Forces Institute of Pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Mitomycin C in the treatment of metastatic transitional cell carcinoma of urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Bladder cancer: results of radiation therapy in 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Infiltrating Carcinoma of the Bladder: Relation of Depth of Penetration of the Bladder Wall to Incidence of Local Extension and Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Carcinoma of the Bladder: Characteristic Modes of Local Invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Analysis in depth of bladder cancer treated by supervoltage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Mitomycin-C in the therapy of far-advanced malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Chemotherapy of Bladder Carcinoma with Cyclophosphamide and Adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Clinical trials with adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

SUPERVOLTAGE IRRADIATION FOR CARCINOMA OF THE URINARY BLADDER

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Pathological aspects and spread of carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Chemotherapy of vesical and prostatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Irradiation and 5-fluorouracil as Adjuvants in the Management of Invasive Bladder Carcinoma. A Cooperative Group Report after 4 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Cis-diamminedichloroplatinum (II). A new anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Cancer of the urogenital tract: bladder cancer. Introduction: problems in definition, classification and etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Current Concepts in Genitourinary Oncology: A Multidisciplinary Approach

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

The surgical attack in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Doxorubicin chemotherapy in advanced transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Cancer of the urogenital tract: bladder cancer. Combined radiotherapy and surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Chemotherapy of human solid tumors with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Adriamycin in advanced urinary tract cancer.Experience in 42 patients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2878%2980008-5

7 January 2021

10.1016/S0305-7372(78)80008-5

Identifiers

DOI

1 reference

14 September 2017

1 reference